NUTXNasdaqServices-Business Services, NECFiscal year ends December 31
Nutex Health Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$191.25+5.15 (+2.77%)
Close on Oct 19, 2026
- Market cap
- $1.34B
- P/E (TTM)
- 7.5
- Dividend yield
- –
Nutex Health Inc. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital division revenue | $813.34M | $847.79M | $844.16M | $950.19M | $761.68M | $592.98M | $449.06M | $261.95M | $244.80M | $228.81M | $218.07M | $202.02M | 96.1% | +6.8% |
| Population health management division revenue | $33.39M | $32.17M | $31.10M | $31.01M | $30.51M | $31.30M | $30.89M | $30.05M | $31.12M | $29.96M | $29.58M | $29.68M | 3.9% | +9.4% |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital division revenue | $813.34M | $847.79M | $844.16M | $950.19M | $761.68M | $592.98M | $449.06M | $261.95M | $244.80M | $228.81M | $218.07M | $202.02M | 96.1% | +6.8% |
| Population health management division revenue | $33.39M | $32.17M | $31.10M | $31.01M | $30.51M | $31.30M | $30.89M | $30.05M | $31.12M | $29.96M | $29.58M | $29.68M | 3.9% | +9.4% |
By region
From the segment and revenue-disaggregation notes of Nutex Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.